Abstract:AIM: To study the immunoprotective effect of liver cancer vaccine with co-transfected IL-2 and B7-1 genes on hepatocarcinogenesis in mice.METHODS: The murine liver cancer cell line Hepal-6 was transfected with IL-2 and/or B7-1 gene via recombinant adenoviral vectors and the liver cancer vaccines were prepared. C57BL/6 mice were immunized with these vaccines and challenged with the parental Hepal-6 cells afterwards. The immunoprotection was investigated and the reactive T cell line was assayed.RESULTS: The immunoprotection of the tumor vaccine was demonstrated. The effect of IL-2 and B7-1 genes co-transfected Hepal-6 liver cancer vaccine (Hep6-IL2/B7 vaccine) on the onset of tumor formation was the strongest. When attacked with wild Hepal-6 cells, the median survival period of the mice immunized with Hep6-IL2/B7 vaccine was the longest (68 days, chi(2) = 7.70-11.69, P < 0.05) and the implanted tumor was the smallest (z =3.20-44.10, P < 0.05). The effect of single IL-2 or B7-1 gene-transfected vaccine was next to the IL2/B7 gene co-transfected group, and the mean survival periods were 59 and 54 days, respectively. The mean survival periods of wild or enhanced green fluorescence protein gene modified vaccine immunized group were 51 and 48 days, respectively. The mice in control group all died within 38 days and the implanted tumor was the largest (z = 3.20-40.21, P < 0.05). The cellular immunofunction test and cytotoxicity study showed that the natural killer (NK) cell, lymphokine activated killer (LAK) cell and cytotoxic T lymphocyte (CTL) activities were significantly increased in mice immunized with the Hep6-IL2/B7 vaccine, (29.5 +/- 2.5%, 65.0 +/- 2.9%, 83.1 +/- 1.5% respectively, compared with other groups, P < 0.05).CONCLUSION: The Hep6-IL2/B7 liver cancer vaccines can induce the mice to produce activated and specific CTL against the parental tumor cells, and demonstrate stronger effect on the hepatocarcinogenesis than single gene modified or the regular tumor vaccine. Therefore, the vaccines may become a novel potential therapy for recurrence and metastasis of HCC.

Active Specific Immunotherapy of Mice Bearing Liver Cancer Using Novel Whole Cell Tumor Vaccine

Experimental Study of Active Specific Immunotherapy for Cervic Cancer with Tumor Vaccine

Experimental Study of Specific Immunotherapy Induced by H22 Autologous Tumor As Whole Tumor Cell Vaccine.

Prevention of Hepatocellular Carcinoma in Mice by IL-2 and B7-1 Genes Co-Transfected Liver Cancer Cell Vaccines

[Application of Fusion Gene Mgm-Csf/hil-2 to Specific Immunotherapy Induced by Hepatic Tumor Cell Vaccine].

[Immunoprotective Effect of IL-2 and B7-1 Gene Co-Transfected Liver Cancer Vaccines on Hepatocarcinogenesis in Mice].

Active Immunotherapy for Mouse Breast Cancer with Irradiated Whole-Cell Vaccine Expressing VEGFR2.

Antitumor therapeutic effect induced by intestine- carcinoma cells vaccine expressing membrane- bound heat shock protein 70

[Application of a Tumor Cell Vaccine Transfected with GM-CSF/IL-2 Fusion Gene for Specific Immunotherapy of Hepatocellular Carcinoma].

[The in Vivo Antitumor Activity of Murine Liver Tumor Vaccine Expressing MIP-1alpha].

A Novel Approach for Cancer Immunotherapy: Tumor Cells with Anchored Superantigen SEA Generate Effective Antitumor Immunity

Immunological evaluation of a novel autologous whole tumor cell vaccine for treating patients with advanced tumor

Efficacy of Leukemia Vaccine Combined 1-MT Immune Treatment of Tumor-Bearing Mice

Influence of Autologous Tumor Vaccine on Th1/Th2 Cytokines and Cytotoxity in Tumor Bearing Mice

The Adoptive Theraputic Effect of Interleukin-12 Gene Transfected Splenocytes from the Mice Immunized by Immunogene Tumor Vaccine on Implanted Liver Cancer

Preparation of Murine Liver Tumor Vaccine Modified by Flt3 Ligand and Its in Vivo Antitumor Activity

Study of immunotherapy of murine myeloma by an IL-21-based tumor vaccine in BALB/C mice.

Study on the cytotoxic T lymphocytes of mice treated with leukemia vaccine

Immunotherapeutic Effect of a Novel Tumor Antigen-Gp96 on Liver Cancer in Mice

Clinical study of active specific immunotherapy in advanced tumors

The Effect of Leukemia Vaccine Treatment on Cellular Immune Function of Tumor Burden Mice